Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine (Q45249479)

11 December 2017

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine (English)

1 reference

11 December 2017

0 references

1 reference

1 reference

1 reference

N A Foudraine

1

1 reference

11 December 2017

R M Hoetelmans

2

1 reference

11 December 2017

J M Lange

3

1 reference

11 December 2017

F de Wolf

4

1 reference

11 December 2017

B H van Benthem

5

1 reference

11 December 2017

J J Maas

6

1 reference

11 December 2017

I P Keet

7

1 reference

11 December 2017

P Portegies

8

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

11 December 2017

1 reference

11 December 2017

351

1 reference

11 December 2017

9115

1 reference

11 December 2017

1547-1551

1 reference

Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Early viral brain invasion in iatrogenic human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Primary human T-lymphotropic virus type III infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Epidemiology of AIDS Dementia Complex in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Comparative pharmacokinetics of two prodrugs of zidovudine in rabbits: enhanced levels of zidovudine in brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

HIV Dementia Scale: a rapid screening test.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

High-performance liquid chromatographic assay for 2'-deoxy-3'-thiacytidine in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Determination of stavudine, a new antiretroviral agent, in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Stavudine: a review of its pharmacodynamic and pharmacokinetic properties and clinical potential in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

A novel approach to assessing the drug susceptibility and replication of human immunodeficiency virus type 1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Cytomegalovirus infection of the central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Diagnosis of viral infections of the central nervous system: clinical interpretation of PCR results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Human immunodeficiency virus type 1 antigen in cerebrospinal fluid. Correlation with clinical neurologic status

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Effect of zidovudine on cerebrospinal fluid in patients with HIV infection and acute neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

Pilot study of the efficacy of atevirdine in the treatment of AIDS dementia complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907333-4

7 January 2021

10.1016/S0140-6736(98)07333-4

Identifiers

DOI

1 reference

11 December 2017

1 reference